Well said OVF! EU just formally announced they will rightfully and thankfully not approve the relatively ineffective, massively expensive and quite harmful drug aducanubab for Mild AD. The US FDA approval is tragic and I expect further evidence will cause it to be taken from the market. The world is desperate for anything truly preventing or mitigating AD and cognitive decline. Tag we’re it.
Further, a new macro study of the factors associated with AD will be released soon focuses on a range of metabolics that seem to connect cortisol like variables for causation. Here’s to better cognition and reduced depression for everyone. Cheers.
Well said OVF! EU just formally announced they will rightfully...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.62M | |||
| Open | High | Low | Value | Volume |
| 2.5¢ | 2.5¢ | 2.4¢ | $22.41K | 903.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 6251438 | 2.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.5¢ | 9666438 | 4 |
View Market Depth
| Last trade - 12.27pm 27/09/2024 (20 minute delay) ? |
| ACW (ASX) Chart |